Business / Finance

RSS

CCM and MD Anderson partner to improve cancer care in China, Singapore

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, announced today that it has signed a multi-year strategic development agreement with The University of Texas MD Anderson Cancer Center, an internationally renowned cancer research, treatment and education center.

6 May 2015

Symbiomix closes $41 million Series A financing and reports positive results from SYM-1219 Phase 2 trial

Symbiomix Therapeutics today announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV).

6 May 2015

Juniper's total revenues increase 19% to $8.3 million in first quarter 2015

Juniper Pharmaceuticals, Inc., today announced financial results for the three-month period ended March 31, 2015.

6 May 2015

Cipher strengthens Canadian dermatology portfolio with acquisition of Vaniqa, Actikerall

Cipher Pharmaceuticals Inc. today announced it has strengthened its Canadian dermatology portfolio by acquiring the Canadian rights to Vaniqa and Actikerall from Almirall S. A., a Spanish pharmaceutical company. Both products have been approved by Health Canada.

6 May 2015

Partners congratulate researchers on forming new biotechnology company

The Children's Hospital of Eastern Ontario, The Ottawa Hospital, the University of Ottawa and McMaster University congratulate its researchers on forming Turnstone Biologics Inc., a biotechnology company focused on developing new treatments for cancer that harness the patient's own immune system.

6 May 2015

Transition Therapeutics acquires worldwide rights from Lilly to develop, commercialize TT701

Transition Therapeutics Inc. today announced its wholly-owned subsidiary, Transition Therapeutics Ireland Limited, has exclusively licensed worldwide rights to a novel small molecule drug candidate ("TT701") from Eli Lilly and Company.

6 May 2015

Deben reports on the work of the Microscopy & Histology Core Facility at the University of Aberdeen

Deben reports on the work of the Microscopy & Histology Core Facility at the University of Aberdeen where a newly installed TEM and camera system have enhanced the services provided to users.

5 May 2015

Lucideon and European partners awarded €3.9m to train industry PhD researchers to develop drug-free antibacterial materials

Lucideon, the materials technology company, together with 9 European consortium partners, has been awarded €3.9m (£2.8m) grant by the European Commission to train industry PhD researchers for the development of drug-free antibacterial materials used for medical applications, such as wound care and implants.

From Lucideon 5 May 2015

CMC Biologics to supply bulk drug substance for Emergent BioSolutions' IXINITY

CMC Biologics, Inc., a global CMO dedicated to process development and production of biopharmaceuticals for clinical and commercial use, today announced that it will supply bulk drug substance for Emergent BioSolutions' recently FDA-approved product, IXINITY® [coagulation factor IX (recombinant)].

5 May 2015

Bio-Techne's net sales increase 19% to $114.2 million in third quarter 2015

Bio-Techne Corporation today reported its financial results for the third quarter ended March 31, 2015.

From ProteinSimple 5 May 2015

Karl Storz installs the OR1 NEO® at Spire Harpenden Hopsital

When Spire Harpenden needed to increase its facilities in response to the ever-growing number of patients choosing the hospital for surgery, it approached KARL STORZ for its market-leading OR1 NEO® integrated operating theatre...

From KARL STORZ 1 May 2015

St. Luke's Celebrates Groundbreaking for New Hospital in Monroe County

St. Luke’s University Health Network has broken ground for the new St. Luke’s Hospital-Monroe Campus, adjacent to Wigwam Road and Route 611, in Bartonsville. This will be the first new hospital in Monroe County in 100 years.

30 Apr 2015

Boston Scientific signs two strategic agreements to bring comprehensive solutions to healthcare systems

Boston Scientific announces the signing of two strategic agreements to advance the company's efforts to bring value based solutions aimed at improving outcomes and reducing the cost of cardiovascular care delivery to healthcare systems.

30 Apr 2015

GNC Holdings reports consolidated revenue of $670.2 million for first quarter 2015

GNC Holdings, Inc., a leading global specialty health, wellness and performance retailer, today reported its financial results for the quarter ended March 31, 2015.

30 Apr 2015

HeartWare International's revenue increases 5% to $70.0 million in first quarter 2015

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $70.0 million for the first quarter ended March 31, 2015, a five percent increase compared to $66.5 million in revenue for the same period of 2014.

30 Apr 2015

Neurocrine reports net loss of $1.2 million for first quarter 2015

Neurocrine Biosciences, Inc. today announced its financial results for the quarter ended March 31, 2015. For the first quarter of 2015, the Company reported a net loss of $1.2 million, or $0.01 loss per share, compared to a net loss of $11.8 million, or $0.17 loss per share, for the same period in 2014.

30 Apr 2015

Zimmer Holdings reports net sales of $1.13 billion for first quarter 2015

Zimmer Holdings, Inc. today reported financial results for the quarter ended March 31, 2015. The Company reported first quarter net sales of $1.13 billion, a decrease of 2.3% reported and an increase of 4.5% constant currency compared to the first quarter of 2014.

30 Apr 2015

Medicure records net revenue of $3.3 million for first quarter 2015

Medicure Inc., a specialty pharmaceutical company, today reported its results from operations for the first quarter ended March 31, 2015.

30 Apr 2015

Cox Enterprises makes investment in Atlanta-based Rimidi

Cox Enterprises announced today an investment in Atlanta-based Rimidi, a digital health company focused on diabetes and other chronic conditions. This marks a major milestone for the company, paving the way for Rimidi's expansion into additional markets and collaborative opportunities.

29 Apr 2015

Validic raises $12.5 million Series B round led by Kaiser Permanente Ventures

Validic, the healthcare industry's leading digital health platform, announced today that it has secured a $12.5 million Series B round led by Kaiser Permanente Ventures, the corporate venture capital arm of Kaiser Permanente. The funding will continue to fuel Validic's rapid growth.

29 Apr 2015

Business / Finance

CCM and MD Anderson partner to improve cancer care in China, Singapore

Symbiomix closes $41 million Series A financing and reports positive results from SYM-1219 Phase 2 trial

Juniper's total revenues increase 19% to $8.3 million in first quarter 2015

Cipher strengthens Canadian dermatology portfolio with acquisition of Vaniqa, Actikerall

Partners congratulate researchers on forming new biotechnology company

Transition Therapeutics acquires worldwide rights from Lilly to develop, commercialize TT701

Deben reports on the work of the Microscopy & Histology Core Facility at the University of Aberdeen

Lucideon and European partners awarded €3.9m to train industry PhD researchers to develop drug-free antibacterial materials

CMC Biologics to supply bulk drug substance for Emergent BioSolutions' IXINITY

Bio-Techne's net sales increase 19% to $114.2 million in third quarter 2015

Karl Storz installs the OR1 NEO® at Spire Harpenden Hopsital

St. Luke's Celebrates Groundbreaking for New Hospital in Monroe County

Boston Scientific signs two strategic agreements to bring comprehensive solutions to healthcare systems

GNC Holdings reports consolidated revenue of $670.2 million for first quarter 2015

HeartWare International's revenue increases 5% to $70.0 million in first quarter 2015

Neurocrine reports net loss of $1.2 million for first quarter 2015

Zimmer Holdings reports net sales of $1.13 billion for first quarter 2015

Medicure records net revenue of $3.3 million for first quarter 2015

Cox Enterprises makes investment in Atlanta-based Rimidi

Validic raises $12.5 million Series B round led by Kaiser Permanente Ventures

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News